What does it say when a national insurer chooses to follow the science before being forced to by law? This year, Aetna updated its coverage policy to recognize Pediatric Acute-onset Neuropsychiatric ...
Tiziana Life Sciences Ltd (NASDAQ:TLSA) said new biomarker data from an expanded-access program showed its experimental intranasal therapy reduced brain inflammation and was associated with ...
Researchers from Brown University and the University of Rochester will lead a multi-institution project to test whether ...
Severe infections requiring hospitalization are associated with a markedly increased long-term IBD risk, with immune-related ...
The chronic autoimmune conditions — both considered types of inflammatory bowel disease — cause a myriad of symptoms ...
Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and ...
The presentation of chronic feline gingivostomatitis is often dramatic. Clinical signs include severe refractory gingivostomatitis, halitosis, ptyalism, and unkempt hair coats due to a lack of ...
Touted by some as a ‘miracle cure-all’, stacking is attracting attention for another reason too: a lack of long-term data and clear regulation. “Peptide stacking simply means using two or more ...
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ('Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces positive new ...
GLP-1 receptor agonists improve glycemic control and weight while reducing cardiovascular events, with tolerability limited by gastrointestinal adverse effects requiring gradual dose escalation.
Oruka Therapeutics, Inc. surged as ORKA-001 beat Skyrizi half-life in Phase 1; see psoriasis market upside, Phase 2a 2H26, ...
Referred to as the “miracle tree,” moringa is loaded with essential vitamins, minerals, antioxidants and plant compounds that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results